Correction to: BTLA⁺CD200⁺ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer

Affiliations

• ¹ S.A. Localio Laboratory, Departments of Surgery, New York University School of Medicine, New York, NY, USA.
• ² Department of Medicine, New York University School of Medicine, New York, NY, USA.
• ³ S.A. Localio Laboratory, Departments of Surgery, New York University School of Medicine, New York, NY, USA. gedalyamil@gmail.com.
• ⁴ Department of Cell Biology, New York University School of Medicine, New York, NY, USA. gedalyamil@gmail.com.
• ⁵ Trinity Health of New England, Waterbury, CT, USA. gedalyamil@gmail.com.